Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $7.2 million.

  • Exagen's Cost of Revenue rose 2973.22% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.5 million, marking a year-over-year increase of 1113.58%. This contributed to the annual value of $22.5 million for FY2024, which is 243.81% down from last year.
  • Per Exagen's latest filing, its Cost of Revenue stood at $7.2 million for Q3 2025, which was up 2973.22% from $6.8 million recorded in Q2 2025.
  • In the past 5 years, Exagen's Cost of Revenue registered a high of $7.2 million during Q3 2025, and its lowest value of $4.7 million during Q1 2021.
  • Its 5-year average for Cost of Revenue is $5.8 million, with a median of $5.8 million in 2022.
  • Per our database at Business Quant, Exagen's Cost of Revenue skyrocketed by 6330.14% in 2021 and then plummeted by 1092.09% in 2023.
  • Quarter analysis of 5 years shows Exagen's Cost of Revenue stood at $4.9 million in 2021, then increased by 27.74% to $6.3 million in 2022, then decreased by 10.92% to $5.6 million in 2023, then fell by 7.86% to $5.2 million in 2024, then surged by 38.45% to $7.2 million in 2025.
  • Its Cost of Revenue was $7.2 million in Q3 2025, compared to $6.8 million in Q2 2025 and $6.4 million in Q1 2025.